1 / 1

Materials and Methods

Normetanephrine. Metanephrine. A. Normal urine specimen. Intensity (cps). Time (min). B. Abnormal urine specimen. Metanephrine. Normetanephrine. Intensity (cps). Time (min). Determination of Urinary Metanephrine and Normetanephrine by LC-MS/MS Following Solid Phase Extraction

muncel
Download Presentation

Materials and Methods

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Normetanephrine Metanephrine A. Normal urine specimen Intensity (cps) Time (min) B. Abnormal urine specimen Metanephrine Normetanephrine Intensity (cps) Time (min) Determination of Urinary Metanephrine and Normetanephrine by LC-MS/MS Following Solid Phase Extraction Zlata D. Clarka, M. Laura Parnasb and Elizabeth L. Frankb aARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108 bDepartment of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84112 Introduction Materials and Methods Results • The determination of metanephrine (M) and normetanephrine (NM) (Figure 1) urine concentrations is used in clinical diagnosis of pheochromocytoma, a rare but potentially fatal tumor arising from the chromaffin cells of the adrenal medulla, as well as related neurogenic tumors. • In our laboratory, a GC-MS method is used to measure M and NM concentrations. Separation and detection are accomplished in 13 minutes. The assay is robust, although double derivatization is required to provide unique MS fragments for both analytes. Increased reagent cost and limited availability prompted our investigation of an alternate method. • The goal of this study was to develop and validate a high-throughput LC-MS/MS method for the measurement of urinary M and NM to replace the current GC-MS based assay. • Assay Overview • M and NM were subjected to acid hydrolysis at 90 °C for 15 min to release the analytes from their glucuronide and sulfate forms. The target compounds were then isolated from the hydrolyzed urine using solid phase extraction (SPE) on PWCX mixed mode cation exchange sorbent (SPEware Corp.) in 96-well format. The SPE eluates were injected directly without a drying step and separated using a Restek Ultra II PFP column (2.1 x 50 mm, 3 µm) on an Agilent 1200 HPLC system. The mobile phase was 0.2% formic acid in water/methanol. Gradient elution produced well-resolved peaks within 2 minutes. Representative chromatograms of normal and abnormal patient specimens are shown in Figure 2. Detection was accomplished using an Applied Biosystems API 3200 triple quadrupole mass spectrometer with electrospray ionization in positive mode. Isotopically labeled internal standards (IS) and a five point calibration curve were used for quantitation in the new LC-MS/MS assay. Data was acquired in multiple-reaction monitoring (MRM) mode with two transitions (quantifier and qualifier) for each analyte and internal standard. • LC-MS/MS System • Applied Biosystems API 3200 triple quadrupole mass spectrometer • CTC Analytics HTC PAL autosampler • Agilent 1200 Series LC system • Restek Ultra II PFP column (2.1 x 50 mm, 3 µm) • Conditions • Mobile phase A 0.2% formic acid in waterLC Gradient: • Mobile phase B 0.2% formic acid in 100% methanol • Flow rate 0.5 mL/min • Injection volume 15 µL • Column temperature 30 °C • Linearity • Standards prepared at 25, 100, 500, 2000, and 7000 nmol/L.. • The method is linear to 7000 nmol/L (Figure 3). • Analytical Sensitivity • LOQ (nmol/L) LOD (nmol/L) • Metanephrine 10 2.5 • Normetanephrine 5 2.5 • Precision • Three concentrations of controls run in duplicate over 20 days. • Mean%CV • Metanephrine (nmol/L) within run between-day total • Low 124 1.6 0.9 1.9 • Level I946 1.02.5 2.7 • Level II 1818 1.6 1.3 2.0 • Mean%CV • Normetanephrine (nmol/L) within run between-day total • Low 432 1.9 1.1 2.2 • Level I3149 1.5 2.1 2.6 • Level II 4725 1.2 2.2 2.5 • Accuracy/Method Comparison • Patient samples (n = 275) were analyzed by both the newly developed method and the method currently in use (Figure 4). • Deming regression: • Metanephrine y= 1.050x – 45.44; Sy/x= 104.98; R= 0.9891 • Normetanephrine y= 1.079x – 191.44; Sy/x= 396.56; R= 0.9635 • Reference Interval • Literature reference intervals (below) were verified using 127 patient urines submitted for Cu or As routine testing. • Metanephrine152 - 1775nmol/d • Normetanephrine273 - 3548 nmol/d Results • FIGURE 1: Chemical structures of metanephrines • FIGURE 2: Example chromatograms • FIGURE 3: Linearity experiments graphical data M - IS Metanephrine Conclusions • We have developed and validated a robust LC-MS/MS method for the measurement of metanephrine and normetanephrine in urine specimens. This method has higher analytical sensitivity and increased throughput compared to the GC-MS method in current use and allows elimination of a cumbersome and costly sample derivatization step. NM - IS M NM • FIGURE 4: Method Comparison References Normetanephrine M • 1. Wu AHB, ed. Tietz Clinical Guide to Laboratory Tests, 4th ed. St. Louis: Saunders, 2006: 1798 pp. • 2. Crockett DK, Frank EL, Roberts WL. Rapid analysis of metanephrine and normetanephrine in urine by gas chromatography-mass spectrometry. ClinChem 2002; 48: 332-337. • 3. Whiting MJ. Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection. Ann ClinBiochem 2009; 46: 129-136. • 4. Taylor RL, Singh RJ. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. ClinChem 2002; 48: 533-539. NM M - IS NM - IS

More Related